Facebook Linkedin Twitter
  • Home
  • News
    • COP Climate Change
    • COVID-19
    • Government
      • Finance
      • Workplace
    • Health & Social Care
      • Coronavirus (COVID-19)
      • Cancer Research
      • Diseases & Conditions
      • Mental Health
      • Pharma
      • Women’s Health
    • Environment
      • Circular Economy
      • Sustainable Development
    • Agriculture
    • Energy
    • Research & Innovation
    • Transport
    • Education
    • Technology
      • Artificial Intelligence
      • Digital Transformation
  • Publications
  • Academic Articles
  • Special Reports
    • Government
    • Health & Social Care
    • Environment
    • Agriculture
    • Energy
    • Research & Innovation
    • Transport
    • Education
    • Finance
    • HR & Training
    • Technology
  • Stakeholders
  • eBooks
    • Asia Analysis
    • North America Analysis
  • Subscribe
Search
Adjacent Open AccessOpen Access GovernmentOpen Access Government
  • Contact Us
  • About Us
  • Editors
  • Our Audience
  • Marketing Information Pack
  • Prestige Contributors
  • Testimonials
Adjacent Open AccessOpen Access GovernmentOpen Access Government
Linkedin
Twitter
Facebook
Instagram
  • Home
  • News
  • Publications
  • Academic Articles
  • Special Reports
  • Stakeholders
  • eBooks
  • Subscribe
  • Agriculture
  • Education
  • Energy
  • Environment
    • COP Climate Change
    • Circular Economy
    • Sustainable Development
  • Government
    • Finance
    • Workplace
  • Health
    • Cancer Research
    • Diseases & Conditions
    • Mental Health
    • Pharma
    • Women’s Health
    • COVID-19
  • Research
  • Technology
    • Artificial Intelligence
    • Digital Transformation
  • Transport
  • North America
  • Asia
Home Julie Blaising – F. Hoffmann-La Roche Ltd

    Julie Blaising

    Principal Scientist
    F. Hoffmann-La Roche Ltd

    Contributor's Details

    Phone: +41 79 564 31 47
    Email: julie.blaising@roche.com
    Website: Visit Website
    LinkedIn: Connect on LinkedIn
    Twitter: Follow on Twitter

    Contributor's Articles

    • Figure 1: Therapeutic relevance of GPCRs in various diseases.
      AI-driven innovations in GPCR ligand synthesis for treating inflammatory diseases
    • Figure 1: Beneficial effects of Kinase inhibition for multiple indications
      Protein kinases for combating inflammatory disease
    • Figure 1: Abnormal pain response in IBD and Endometriosis.
      Therapeutic potential of the endocannabinoid system to treat chronic pain in inflammatory disease
    • MAGL inhibition: A novel treatment option for combating inflammatory disease?
    Open Access Government

    Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

    Follow Us

    • LinkedIn
    • Twitter (X)
    • Facebook

    Resources

    • Stakeholders
    • Academic Articles
    • Publications
    • eBooks

    Quick Links

    • Contact Us
    • About Us
    • Our Editors
    • Our Audience
    • Prestige Contributors
    • Testimonials

    Legal & Marketing

    • Terms & Conditions
    • Privacy Policy
    • GDPR Info
    • GDPR Privacy Policy
    • Marketing Info Pack
    • Fee Schedule

    As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

    © Adjacent Digital Politics Ltd